Encompass Health Prices $100 Million Private Offering of Additional 5.875% Senior Notes Due 2034
Encompass Health Corp. has announced the pricing of a private offering of an additional $100 million aggregate principal amount of 5.875% senior notes due 2034, providing the company with additional capital that it plans to use primarily to reduce borrowings under its senior secured revolving credit facility.
The additional notes were priced at 98.75% of their principal amount and will form part of the same class as Encompass Health’s existing 5.875% senior notes due 2034, which were originally issued in May 2026. The transaction is expected to close on August 13, 2026, subject to customary closing conditions.
The offering represents another step in Encompass Health’s broader approach to managing its capital structure and financing needs. Rather than using the proceeds to fund a new operating initiative or acquisition, the company intends to combine the net proceeds from the additional notes with cash on hand to repay outstanding amounts under its revolving credit facility.
Additional $100 Million in Long-Term Debt
Under the terms of the transaction, Encompass Health will issue an additional $100 million in principal amount of its 5.875% senior notes maturing in 2034.
The additional notes will constitute a reopening of the company’s existing 5.875% senior notes due 2034. Because the securities will be treated as part of the same class, they will generally carry the same terms as the existing notes, apart from differences relating to the issuance date and offering price.
The notes were priced at 98.75% of principal value. As a result, the company will receive less than the full $100 million face value before accounting for applicable transaction expenses and other adjustments.
The additional notes will pay interest at a fixed annual rate of 5.875%. Interest will be paid twice a year in arrears, on June 1 and December 1, with the first interest payment on the additional notes scheduled for December 1, 2026.
The structure provides Encompass Health with long-term financing extending to 2034, while also allowing the company to use the proceeds to address shorter-term borrowing under its revolving credit facility.
Proceeds to Repay Revolving Credit Facility
Encompass Health plans to use the net proceeds from the offering, together with cash already held by the company, to repay outstanding amounts under its senior secured revolving credit facility.
The planned use of proceeds is significant because it reflects a capital-management strategy focused on adjusting the company’s mix of financing rather than simply increasing its available liquidity.
By issuing long-term senior notes and using the proceeds to repay revolving credit borrowings, Encompass Health can replace a portion of its existing secured revolving debt with longer-term unsecured financing.
The approach may provide the company with additional flexibility within its revolving credit facility once the repayment is completed. Maintaining access to revolving credit can be valuable for a healthcare company because it provides a source of liquidity that can potentially be used for working capital, operational requirements and other corporate purposes.
The transaction also gives Encompass Health an opportunity to manage the maturity profile of its debt by raising financing that does not mature until 2034.
Existing Notes Issued in May 2026
The new securities are being issued as additional notes under the company’s existing 5.875% senior notes due 2034, which were originally issued in May 2026.
Reopening an existing bond issue can provide companies with an efficient way to raise additional capital without creating an entirely separate series of debt securities. The additional notes share the same core terms as the existing notes, helping maintain consistency between the two portions of the debt.
For investors, the additional notes will be treated as part of the same class as the existing notes, subject to the terms outlined in the offering documentation.
The reopening structure also allows Encompass Health to build on its existing capital markets financing rather than introducing a completely new maturity and coupon structure.
Senior Unsecured Guarantees
The additional notes will be jointly and severally guaranteed on a senior unsecured basis by all of Encompass Health’s existing and future subsidiaries that guarantee borrowings under the company’s credit agreement and other capital markets debt.
The guarantees are an important element of the financing structure because they extend the credit support of qualifying subsidiaries to the obligations associated with the notes.
The senior unsecured status means the notes represent senior obligations of the company, while the guarantees provide additional support from the subsidiaries that fall within the relevant guarantee requirements.
The arrangement mirrors the guarantee structure associated with the company’s existing capital markets debt and credit agreement.
Private Offering Structure
The additional notes are not being offered to the general public.
In the United States, the securities are being offered only to persons reasonably believed to be qualified institutional buyers, or QIBs, under Rule 144A of the Securities Act of 1933.
The notes are also being offered to certain non-U.S. persons in transactions outside the United States under Regulation S of the Securities Act.
This private offering structure is commonly used by companies accessing institutional debt investors without conducting a registered public securities offering.
Because the additional notes and related guarantees have not been registered under the Securities Act or applicable state securities laws, they may not be offered or sold in the United States unless they are registered or an applicable exemption from registration requirements is available.
The securities therefore have restrictions governing their distribution and resale.
No Public Offering
Encompass Health emphasized that the announcement is intended for informational purposes and does not constitute an offer to sell or a solicitation of an offer to purchase securities.
The company also stated that the offering does not constitute an offer, solicitation or sale of securities in any jurisdiction where such activity would be unlawful.
These provisions are particularly relevant because the transaction is structured as a private securities offering rather than a registered public offering.
Investors considering the additional notes would need to review the applicable offering documentation and satisfy the relevant eligibility and securities-law requirements.
Capital Management Strategy
The decision to use the proceeds to repay revolving credit borrowings highlights Encompass Health’s focus on capital structure management.
Companies frequently use a combination of secured credit facilities, senior notes and cash to finance operations and maintain liquidity. The optimal balance can change depending on interest rates, operating performance, investment plans and broader financial conditions.
For Encompass Health, issuing additional long-term notes while reducing revolving credit facility borrowings can provide a different mix of financing sources.
The transaction also potentially gives the company greater visibility into its long-term interest obligations because the new notes carry a fixed 5.875% interest rate and mature in 2034.
At the same time, the company will continue to have obligations associated with the additional debt, including periodic interest payments and eventual repayment of principal at maturity.
Importance of Long-Term Financing for Healthcare Providers
Healthcare providers require substantial financial resources to maintain and expand their operations. Investments can include hospitals and rehabilitation facilities, clinical equipment, technology infrastructure, workforce development and other healthcare services.
Encompass Health operates in the inpatient rehabilitation sector, where demand for specialized post-acute care is influenced by factors including population aging, chronic disease prevalence and the need for recovery services following serious medical events.
Long-term financing can support financial flexibility as the company continues operating in this environment.
The 2034 maturity of the additional notes gives Encompass Health a relatively long financing horizon. This can help align the debt with the company’s longer-term business planning while allowing it to manage nearer-term credit facility obligations.
Expected Closing on August 13
The transaction is currently expected to close on August 13, 2026, assuming customary closing conditions are satisfied.
Until closing, the offering remains subject to the conditions and requirements outlined in the applicable transaction documentation.
Once completed, Encompass Health will have issued an additional $100 million of its existing 5.875% senior notes due 2034.
The company will then apply the net proceeds, together with cash on hand, toward outstanding borrowings under its senior secured revolving credit facility.
Potential Impact on Liquidity
Although the transaction increases the company’s outstanding senior notes, the planned repayment of revolving credit borrowings means the financing should be viewed in the broader context of Encompass Health’s overall capital structure.
The use of proceeds is aimed at reshaping existing borrowings rather than simply raising additional funds for unrestricted spending.
Reducing utilization of a revolving credit facility can potentially restore borrowing capacity under that facility, subject to its terms and availability. Maintaining access to undrawn revolving capacity can provide companies with an additional source of liquidity when operating or market conditions change.
For Encompass Health, that flexibility may be useful as it manages ongoing operational requirements and evaluates future investments.
A Structured Approach to Financing
The additional senior notes offering illustrates Encompass Health’s continued use of the debt capital markets to manage its financing requirements.
The company is raising $100 million through securities with a 5.875% coupon and a 2034 maturity, while simultaneously planning to repay outstanding amounts under its revolving credit facility using the proceeds and cash on hand.
The transaction also builds on the existing senior notes issued earlier in 2026, creating an expanded class of securities with consistent terms.
From a capital-management perspective, the approach provides Encompass Health with long-term financing while helping reduce its reliance on its revolving credit facility.
The successful completion of the offering will add another $100 million to Encompass Health’s 5.875% senior notes due 2034. The company expects to use the proceeds, together with available cash, to repay outstanding revolving credit facility borrowings.
The transaction reflects a strategic effort to manage the company’s debt structure, maintain liquidity and align financing with longer-term financial planning.
With the additional notes carrying a fixed 5.875% interest rate and extending to 2034, Encompass Health is securing long-term capital while reallocating a portion of its existing borrowing exposure.
The offering is being conducted through private-market channels under Rule 144A and Regulation S, limiting participation to eligible institutional and non-U.S. investors under the applicable securities regulations.
Subject to customary closing conditions, the transaction is expected to be completed on August 13, 2026. Following completion, Encompass Health will focus on applying the financing proceeds toward its stated debt repayment objective.
Overall, the $100 million offering represents a capital structure and debt-management transaction for Encompass Health, providing long-term financing while supporting the company’s effort to manage revolving credit borrowings and preserve financial flexibility for its healthcare operations.
Source link: https://www.encompasshealth.com/
